Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

James Edward Muller, M.D.

Co-Author

This page shows the publications co-authored by James Muller and Samuel Shubrooks.
Connection Strength

0.171
  1. A patent infarct-related artery is associated with reduced long-term mortality after percutaneous transluminal coronary angioplasty for postinfarction ischemia and an ejection fraction <50%. Circulation. 1996 Apr 15; 93(8):1496-501.
    View in: PubMed
    Score: 0.041
  2. Significance of location (anterior versus inferior) and type (Q-wave versus non-Q-wave) of acute myocardial infarction in patients undergoing percutaneous transluminal coronary angioplasty for postinfarction ischemia. Am J Cardiol. 1995 Sep 01; 76(7):431-5.
    View in: PubMed
    Score: 0.039
  3. Similar results of percutaneous transluminal coronary angioplasty for women and men with postmyocardial infarction ischemia. J Am Coll Cardiol. 1994 Jan; 23(1):35-9.
    View in: PubMed
    Score: 0.035
  4. ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats: the clinical and public health implications for the prevention and control of cardiovascular diseases. J Am Coll Cardiol. 2007 Mar 27; 49(12):1373-412.
    View in: PubMed
    Score: 0.022
  5. ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats: the clinical and public health implications for the prevention and control of cardiovascular diseases. Circulation. 2007 Mar 27; 115(12):1656-95.
    View in: PubMed
    Score: 0.022
  6. Angioscopic assessment of coronary lesions underlying thrombus. Am J Cardiol. 1997 Apr 15; 79(8):1106-9.
    View in: PubMed
    Score: 0.011
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.